Drug recall · March 21, 2018
methylPREDNISolone Sodium Succinate for Injection recall
Why: Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
methylPREDNISolone Sodium Succinate for Injection, USP, 40 mg* per vial, Single-Dose Vial, Rx only, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-807-05.
- Lots / codes
Lot #: AJM601, Exp. Jul-2018; AJM701, AJM702, Exp. Dec-2018
- Quantity
- 205,370 vials
- Company
- Sagent Pharmaceuticals Inc, Schaumburg, IL
- Distribution
- Nationwide in the USA.
- Initiated
- March 5, 2018 · Voluntary: Firm initiated
- Classified
- March 12, 2018
- Reported
- March 21, 2018
- Ended
- April 15, 2020
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylprednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.